CME and Disclosure
Speaker Disclosure
University of California, Irvine School of Medicine Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
The following speakers have disclosed the following relationship with an ineligible company:
| Speaker Name | Role in Activity | Name of Ineligible Company | Nature of Relevant Relationship | Conflict Resolution Method |
| Rebecca Abelman, MD | Speaker | Merck | Grants/Research Support | This presentation has been reviewed by the conference Clinical Director, who reports the stated disclosures have had no affect on the content of this presentation. |
| Shibani Mukerji, MD, PhD | Speaker | Amgen Gilead Sciences | Stocks or stock options, excluding diversified mutual funds | This presentation has been reviewed by the conference Clinical Director, who reports the stated disclosures have had no affect on the content of this presentation. |
The following speakers and planners have indicated they have no relevant financial relationships to disclose:
Brett Feldman, PA-C; Geeta Gupta, MD; Kelly Johnson, MD, MPH; Christopher Ried, MD; David Spach, MD; Christian Takayama, MD

